Virogates A/S Feed

2026-08-03 15:21:00 ViroGates announces changes to its commercial organization

2026-05-07 13:12:00 ViroGates announces its Interim Report for Q1-2026 10,90 DKK | +0,93% | 0,01 MDKK

2026-04-23 20:15:00 Resolutions from the Annual General Meeting of ViroGates A/S

2026-04-08 22:37:00 ViroGates submits its De Novo application to the U.S. FDA for suPARnostic® TurbiLatex 10,90 DKK | -2,68% | 0,00 MDKK

2026-04-08 16:19:00 ViroGates gives notice to convene the Annual General Meeting on 23 April 2026 11,20 DKK | +5,66% | 0,00 MDKK

2026-03-26 15:10:00 ViroGates announces its Annual Report 2025: Revenue growth and improved operating result as strategic transition towards preventive health and longevity continues 11,15 DKK | 0,00% | 0,00 MDKK

2025-12-12 12:15:00 ViroGates publishes its financial calendar for 2026 14,20 DKK | -3,73% | 0,03 MDKK

2025-12-12 11:33:00 ViroGates announces financial guidance for 2026 14,20 DKK | -3,73% | 0,03 MDKK

2025-11-28 15:39:00 ViroGates’ capital raise of DKK 19.3 million and issue of 1,547,412 shares have been registered and settled 17,15 DKK | +7,19% | 0,03 MDKK

2025-11-20 14:30:00 suPAR Remedy, LLC announces the Completion of the public tender offer to the shareholders of ViroGates. 16,70 DKK | +22,34% | 0,17 MDKK

2025-11-18 07:41:00 ViroGates announces a directed issue of nominally 1,547,412 shares, raising approximately DKK 19.3 million 13,30 DKK | +6,83% | 0,10 MDKK

2025-11-17 23:31:00 ViroGates announces a plan to offer new shares through a directed issue without preemptive rights for existing shareholders 13,30 DKK | +6,83% | 0,10 MDKK

2025-11-12 08:40:00 suPAR Remedy, LLC announces the outcome of the Public Tender Offer to the shareholders of ViroGates. 12,90 DKK | +7,05% | 0,13 MDKK

2025-11-06 13:34:00 ViroGates announces its Interim Report for Q1-Q3 2025 13,15 DKK | +0,38% | 0,05 MDKK

2025-10-23 15:29:00 ViroGates announces Notice of Potential Equity / Capital Raise 12,95 DKK | 0,00% | 0,01 MDKK

2025-10-17 14:36:00 ViroGates Receives FDA Feedback on 513(g) Request, confirming Regulatory Pathway for U.S. Market Entry 12,80 DKK | -0,78% | 0,05 MDKK

2025-10-15 15:22:00 ViroGates announces the publication of a Board Statement in relation to the Tender Offer from suPAR Remedy, LLC 12,75 DKK | 0,00% | 0,14 MDKK

2025-10-10 08:52:00 ViroGates announces the receipt of an Announcement and Official Tender Offer Document from suPAR Remedy LLC 12,70 DKK | +1,60% | 0,11 MDKK

2025-10-08 08:53:00 suPAR Remedy, LLC announces public tender offer to the shareholders of ViroGates A/S at a 40% premium 12,75 DKK | +31,44% | 0,79 MDKK

2025-08-21 11:25:00 ViroGates announces its Half-Year Report for H1 2025 9,70 DKK | -0,61% | 0,02 MDKK

2025-06-16 15:30:00 ViroGates and GENSPEED achieve proof of concept for their suPARnostic® POC+ targeted at the Longevity Testing Market 9,20 DKK | 0,00% | 0,00 MDKK

2025-05-21 16:16:00 Resolutions from the Extraordinary General Meeting of ViroGates A/S

2025-05-06 11:55:00 ViroGates gives notice to convene an Extraordinary General Meeting on 21 May 2025 6,70 DKK | +3,08% | 0,03 MDKK

2025-05-01 17:39:00 ViroGates announces its Q1 report for 2025 6,40 DKK | -1,84% | 0,00 MDKK

2025-04-24 21:17:00 Resolutions from the Annual General Meeting of ViroGates A/S

2025-04-07 13:25:00 Notice to convene the annual general assembly 6,88 DKK | 0,00% | 0,08 MDKK

2025-03-20 19:23:00 ViroGates announces its Annual Report 2024 8,30 DKK | -2,92% | 0,05 MDKK

2025-03-19 18:46:00 ViroGates announces an amendment to its agreement with Sobi 8,55 DKK | -2,29% | 0,00 MDKK

2025-01-16 22:31:00 ViroGates issues warrants to key employees 12,50 DKK | -3,85% | 0,09 MDKK

2024-12-19 18:08:00 ViroGates publishes its financial calendar for 2025 12,10 DKK | -6,20% | 0,04 MDKK

2024-12-19 17:20:00 ViroGates announces financial guidance for 2025 12,10 DKK | -6,20% | 0,04 MDKK

2024-12-16 17:16:00 ViroGates announces a reorganisation of its marketing and sales department and revises its guidance for the year 13,10 DKK | 0,00% | 0,03 MDKK

2024-11-11 17:05:00 ViroGates’ capital raise of DKK 8.2 million and issue of 1,289,510 new shares have been registered 22,00 DKK | +46,67% | 2,68 MDKK

2024-11-07 12:05:00 ViroGates announces its Interim Report for Q1-Q3 2024: Revenues are disappointing, but strategic refocusing will pave the way for future growth 9,80 DKK | +1,03% | 0,05 MDKK

2024-10-14 18:37:00 ViroGates announces a distribution agreement with suPAR Health and a directed issue of shares to suPAR Remedy LLC 6,90 DKK | +25,45% | 0,92 MDKK

2024-08-15 12:30:00 ViroGates announces its half-year report for H1 2024: Revenue for the first half-year of 2024 falls behind the same period in 2023 due to lower activity among research customers 6,40 DKK | +7,56% | 0,00 MDKK

2024-07-17 14:45:00 ViroGates announces revised financial guidance for 2024 6,10 DKK | +0,83% | 0,05 MDKK

2024-05-02 11:20:16 ViroGates announces its Interim Report for Q1, 2024: Quarterly revenue up 14% compared to Q1, 2023 6,20 DKK | -6,06% | 0,03 MDKK

2024-04-25 20:29:09 Resolutions from the Annual General Meeting of ViroGates A/S 6,50 DKK | -11,92% | 0,00 MDKK

2024-04-15 18:36:24 ViroGates announces the outcome of its Q-Submission filing for suPARnostic® TurbiLatex with the US FDA and the overall timeline for filing a submission of a 510k/“De Novo” application with the FDA 6,00 DKK | 0,00% | 0,19 MDKK

2024-04-10 13:46:41 ViroGates gives notice to convene the Annual General Meeting on 25 April 2024 6,66 DKK | +4,39% | 0,13 MDKK

2024-03-21 12:26:32 ViroGates announces its Annual Report 2023: Revenue was affected by the loss of COVID-19 customers and a difficult transition into general triage 7,52 DKK | -0,27% | 0,15 MDKK

2023-12-21 16:25:48 Subscription of shares by majority shareholder in relation to the recently completed rights emission in ViroGates A/S 7,18 DKK | -28,20% | 1,04 MDKK

2023-12-21 16:24:32 ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19 7,18 DKK | -28,20% | 1,04 MDKK

2023-12-21 16:22:59 ViroGates publishes its financial calendar for 2024 7,18 DKK | -28,20% | 1,04 MDKK

2023-12-21 16:20:42 ViroGates announces financial guidance for 2024 7,18 DKK | -28,20% | 1,04 MDKK

2023-12-19 16:03:16 ViroGates' capital raise of DKK 13.9 million and issue of 3,097,047 new shares have been registered 10,00 DKK | -31,74% | 0,15 MDKK

2023-12-15 10:58:39 ViroGates announces the outcome of its rights issue 8,00 DKK | +11,11% | 0,07 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode